In short: 

It’s the first time oral immunotherapy will be offered in mainstream care, outside a clinical trial setting.

Any baby under the age of 12 months, diagnosed with a peanut allergy and being cared for at one of the participating hospitals is eligible.

What’s next?

The National Allergy…